Molecular Pharmacology Fast Forward. Published on November 26, 2019 as DOI: 10.1124/mol.119.117549 This article has not been copyedited and formatted. The final version may differ from this version. MOL Manuscript # 117549 Characterization and optimization of the novel TRPM2 antagonist tatM2NX Cruz-Torres, I.; Backos, D.S.; and Herson, P.S. Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA (I.C.T, P.S.H.) Department of Pharmaceutical Sciences, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA (D.S.B.) Downloaded from Department of Anesthesiology, University of Colorado School of Medicine, Aurora, CO, USA (P.S.H.) molpharm.aspetjournals.org Neuronal Injury & Plasticity Program, University of Colorado School of Medicine, Aurora, CO, USA (I.C.T, P.S.H.) Corresponding author: Ivelisse Cruz-Torres (
[email protected]), Paco S. at ASPET Journals on September 29, 2021 Herson (
[email protected]); telephone: 303-724-6628; fax: 303-724-1761 Address: Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA 1 Molecular Pharmacology Fast Forward. Published on November 26, 2019 as DOI: 10.1124/mol.119.117549 This article has not been copyedited and formatted. The final version may differ from this version. MOL Manuscript # 117549 Running title: Characterization of the TRPM2 antagonist tatM2NX Number of text pages: 32 Number of tables: 2 Number of figures: 4 Number of references: 75 Downloaded from Number of words abstract: